These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 23485455)
21. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Lim JH; Lee YM; Chun YS; Chen J; Kim JE; Park JW Mol Cell; 2010 Jun; 38(6):864-78. PubMed ID: 20620956 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth. Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580 [TBL] [Abstract][Full Text] [Related]
23. uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma. Gupta R; Nalla AK; Gogineni VR; Chetty C; Bhoopathi P; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS PLoS One; 2011 Feb; 6(2):e17123. PubMed ID: 21347260 [TBL] [Abstract][Full Text] [Related]
24. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061 [TBL] [Abstract][Full Text] [Related]
25. Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Bordoli MR; Stiehl DP; Borsig L; Kristiansen G; Hausladen S; Schraml P; Wenger RH; Camenisch G Oncogene; 2011 Feb; 30(5):548-60. PubMed ID: 20856199 [TBL] [Abstract][Full Text] [Related]
26. Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth. Covello KL; Simon MC; Keith B Cancer Res; 2005 Mar; 65(6):2277-86. PubMed ID: 15781641 [TBL] [Abstract][Full Text] [Related]
27. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470. Yazaki T; Takamiya Y; Costello PC; Mineta T; Menon AG; Rabkin SD; Martuza RL J Neurooncol; 1995; 23(1):23-9. PubMed ID: 7542695 [TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor 3 biology: complexities and emerging themes. Duan C Am J Physiol Cell Physiol; 2016 Feb; 310(4):C260-9. PubMed ID: 26561641 [TBL] [Abstract][Full Text] [Related]
30. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas. Bujko M; Kober P; Rusetska N; WakuĊa M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. Makino Y; Kanopka A; Wilson WJ; Tanaka H; Poellinger L J Biol Chem; 2002 Sep; 277(36):32405-8. PubMed ID: 12119283 [TBL] [Abstract][Full Text] [Related]
32. The Effects of Silencing the Her2 Gene on Proliferation and Angiogenesis of Meningioma Cells Wang S; Liu X; Wang W; Tu Y; Wang C; Mei J; Xiong J Ann Clin Lab Sci; 2018 Sep; 48(5):580-586. PubMed ID: 30373861 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics. Nguyen MP; Lee S; Lee YM Arch Pharm Res; 2013 Mar; 36(3):252-63. PubMed ID: 23440580 [TBL] [Abstract][Full Text] [Related]
34. The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas. Ding MH; Wang Z; Jiang L; Fu HL; Gao J; Lin XB; Zhang CL; Liu ZY; Shi YF; Qiu GZ; Ma Y; Cui DX; Hu GH; Jin WL Biomaterials; 2015 Jul; 56():165-78. PubMed ID: 25934289 [TBL] [Abstract][Full Text] [Related]
35. Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth. Medhkour A; Van Roey M; Sobel RA; Fingert HJ; Lee J; Martuza RL J Neurosurg; 1989 Oct; 71(4):545-50. PubMed ID: 2477514 [TBL] [Abstract][Full Text] [Related]
36. DNA methylation in the malignant transformation of meningiomas. Gao F; Shi L; Russin J; Zeng L; Chang X; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Mack WJ; Wang K PLoS One; 2013; 8(1):e54114. PubMed ID: 23349797 [TBL] [Abstract][Full Text] [Related]
37. Basic fibroblast growth factor and fibroblast growth factor receptor-i in human meningiomas. Yi W; Chen J; Golwa FH; Xue D J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):75-7. PubMed ID: 15934314 [TBL] [Abstract][Full Text] [Related]
38. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. Patel KS; Kejriwal S; Sun MM; Thammachantha S; Duong C; Chan A; Cherian N; Romiyo P; Gordon LK; Yong W; Wadehra M; Yang I J Neurooncol; 2020 Mar; 147(1):15-24. PubMed ID: 31981014 [TBL] [Abstract][Full Text] [Related]
39. The ever-expanding role of HIF in tumour and stromal biology. LaGory EL; Giaccia AJ Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486 [TBL] [Abstract][Full Text] [Related]
40. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Hickey MM; Simon MC Curr Top Dev Biol; 2006; 76():217-57. PubMed ID: 17118268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]